Compounds > 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid)
Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) and etidronate

1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) has been researched along with etidronate in 1 studies

Compound Research Comparison

Studies
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))		Trials
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))		Recent Studies (post-2010)
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))		Studies
(etidronate)		Trials
(etidronate)		Recent Studies (post-2010) (etidronate)
25482,819510432

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afarideh, H; Bagheri, R; Maragheh, MG; Samani, AB; Shirmardi, SP1

Other Studies

1 other study(ies) available for 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) and etidronate

ArticleYear
Study of Bone Surface Absorbed Dose in Treatment of Bone Metastases via Selected Radiopharmaceuticals: Using MCNP4C Code and Available Experimental Data.
    Cancer biotherapy & radiopharmaceuticals, 2015, Volume: 30, Issue:4

    Topics: Bone Marrow; Bone Neoplasms; Etidronic Acid; Femur; Humans; Organophosphorus Compounds; Radiation Dosage; Radiopharmaceuticals

2015